Press release: AMYPAD project launch

05/10/2016: Academia and industry join forces in largest European initiative to investigate the value of β‐amyloid brain scans as a diagnostic and therapeutic marker for Alzheimer’s disease

This project has received funding from the Innovative Medicines Initiative 2 Joint undertaking under grant agreement No 115952. This Joint Undertaking receives support from the European Union’s Horizon 2020 research and innovation programme and EFPIA.

Acknowledgements, Legal Notice and Privacy Policy